Renal Cancer - Results from #3120

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma. December 17, 2019

The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma. December 17, 2019

Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities. December 16, 2019

The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma. December 16, 2019

First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options. December 16, 2019

Metabolic syndrome is associated with improved cancer-specific survival in patients with localized clear cell renal cell carcinoma. December 13, 2019

Prognostic value of immune-related genes in clear cell renal cell carcinoma. December 13, 2019

D-loop Mutations in Renal Cell Carcinoma Improve Predictive Accuracy for Cancer-Related Death by Integrating with Mutations in the NADH Dehydrogenase Subunit 1 Gene. December 13, 2019

Post-ablation syndrome after percutaneous cryoablation of small renal tumors: A prospective study of incidence, severity, duration, and effect on lifestyle. December 12, 2019

A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma. December 12, 2019

GABRQ expression is a potential prognostic marker for patients with clear cell renal cell carcinoma. December 12, 2019

Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. December 11, 2019

MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway. December 11, 2019

Expression of the Sonic Hedgehog pathway components in clear cell renal cell carcinoma. December 11, 2019

Identification of tumor size as the only factor associated with non-diagnostic biopsies in patients with small renal masses. December 10, 2019

Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence. December 10, 2019

Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma. December 10, 2019

Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study. December 9, 2019

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. December 9, 2019

Cytoreductive nephrectomy: does CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangiogéniques) change everything? December 9, 2019

Page 157 of 456